In a phase 2 trial, lusvertikimab significantly improves clinical and endoscopic outcomes in patients with moderate to severe ...

Thetis Pharmaceuticals LLC (“Thetis”), a clinical-stage company developing TP-317, a first-in-class, small molecule drug ...

We recently published a list of 10 Best Weight Loss Drug Stocks to Buy According to Analysts. In this article, we are going ...

Reimer and colleagues 1 report results from a randomized, double-blind, placebo-controlled study of healthy individuals who received 40 mg daily ... of therapy. Gastroenterology 137, 80–87 ...

OSE Immunotherapeutics Reports Full Phase 2 Induction Results for Anti-IL-7R mAb Lusvertikimab in Ulcerative Colitis at the 20th Congress of ...

Full analysis of Phase 2 results, including data from the 52-week treat-through LTE phase, is expected to inform development strategy and partnership opportunities for VTX958 SAN DIEGO, Feb. 18, 2025 ...

Correspondence to Professor John Dent, Department of Gastroenterology & Hepatology ... Symptoms were recorded during treatment with 40 mg of esomeprazole for 2 weeks. The main outcome measure was RDQ ...

Kinder unter 12 Jahren: Das Arzneimittel sollte in der Regel in dieser Altersgruppe nicht angewendet werden. Kinder und Jugendliche unter 18 Jahren: In dieser Altersgruppe sollte das Arzneimittel nur ...

OTTAWA — Pierre Poilievre says a Conservative government would bring in mandatory life sentences for those convicted of trafficking, production and distribution of over 40 mg of fentanyl.

For both induction and maintenance therapy, subcutaneous guselkumab significantly improves clinical outcomes in patients with ...

Drinking two small glasses of cherry juice a day may reduce gut inflammation and boost quality of life in bowel disease ...